Okabena Investment Services Inc Amgen Inc Transaction History

Okabena Investment Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.29 Million - $1.57 Million	5,702 Added 10559.26%	5,756 $1.39 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $12,367 - $15,714	54 New	54 $14,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $6,578 - $7,277	-30 Reduced 17.75%	139 $34,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $33,610 - $38,464	169 New	169 $38,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Okabena Investment Services Inc, based on Form 13F filings with the SEC.

Stay updated on Okabena Investment Services Inc with notifications on news.